Stay updated with breaking news from Mark Trusheim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Single-dose gene therapy, betibeglogene autotemcel, may represent a cure for most with beta-thalassemia, but it costs a record-high $2.8 million. Details on how coverage will work remain murky
MedCity News Innovative payment models to support cell and gene therapies on the rise (video) As precision medicine gains steam, the question arises: how can reimbursement models evolve to support these often costly therapies and ensure patient access is not blocked? Drugmakers and payers are working together to find some answers. Shares1 As the precision medicine field evolves and the science behind personalized therapies for complex conditions surges ahead, reimbursement models are racing to catch up. Precision medicine treatments, like cell and gene therapies, tend to have high price ...